NTRA
Natera, Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +10.5% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 215.03K | $85.48M | n/a | −3 |
| Q2 2026 | 160 | 0 | 103.68M | $28.12B | +5 | −6 |
| Q1 2026 | 164 | +3 | 98.65M | $19.54B | +6 | −4 |
| Q4 2025 | 160 | 0 | 102.31M | $23.44B | +1 | n/a |
| Q3 2025 | 23 | +1 | 81.70M | $13.15B | +1 | −1 |
| Q2 2025 | 20 | -1 | 57.32M | $9.68B | n/a | −1 |
| Q1 2025 | 18 | 0 | 31.15M | $4.40B | n/a | n/a |
| Q4 2024 | 18 | 0 | 26.97M | $4.27B | n/a | n/a |
| Q3 2024 | 17 | -1 | 21.42M | $2.72B | n/a | −1 |
| Q2 2024 | 18 | n/a | 16.29M | $1.76B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 6.74M | +134.9% | $1.07B | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | Duquesne Family Office ✦ | 3.57M | 0.0% | $564.63M | 15.9% | Held | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.24M | +15.7% | $512.90M | 0.1% | ▲ Add | 3 | SEC ↗ ×4 |
| 4 | State Street Global Advisors ✦ (pasif) | 2.99M | n/a | $473.47M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 2.23M | +6.8% | $355.81M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 1.43M | -37.1% | $226.52M | 0.2% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (pasif) | 1.42M | +3.0% | $224.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 945.51K | +21.8% | $149.67M | 0.2% | ▲ Add | 3 | SEC ↗ ×4 |
| 9 | ARK Investment Management ✦ | 887.71K | +29.1% | $140.52M | 1.2% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 806.33K | -22.2% | $127.64M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 11 | Marshall Wace ✦ | 434.44K | -3.7% | $68.77M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 396.84K | -72.0% | $62.82M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 13 | Capital World Investors ✦ | 396.42K | 0.0% | $62.75M | 0.0% | Held | 3 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 394.00K | -13.6% | $62.37M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 374.37K | -3.7% | $59.26M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 305.24K | -56.2% | $48.32M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 296.37K | +874.1% | $46.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 109.50K | +9.9% | $17.33M | 0.2% | ▲ Add | 3 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 755 pemegang, 120.14M saham, $20.15B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 627 lbr · $257,003
Director · 605 lbr · $248,847
Director · 962 lbr · $392,745
Director · 125 lbr · $51,631
Director · 211 lbr · $86,974
Director · 255 lbr · $105,995
Director · 165 lbr · $68,751
Director · 200 lbr · $81,300
Director · 80 lbr · $32,484
Director · 50 lbr · $20,258
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi